|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/09 | (2006.01) |
| A61K 39/092 | (2013.01) | ||
| A61K2039/58 | (2013.01) | ||
| A61K2039/6037 | (2013.01) | ||
| A61K2039/70 | (2013.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 37/04 | (2018.01) |
| (11) | Number of the document | 3570879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18701573.0 |
| Date of filing the European patent application | 2018-01-05 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2018/050084 |
| Date | 2018-01-05 |
| (87) | Number | WO 2018/134693 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 201762448485 P | 2017-01-20 | US |
| (72) |
COOPER, David , US
JANSEN, Kathrin Ute , US
PRIDE, Michael William , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES |
| IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES |